Fidelity Investments’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-3,478,172
Closed -$279M 2782
2016
Q4
$279M Sell
3,478,172
-1,416,915
-29% -$112M 0.04% 526
2016
Q3
$390M Sell
4,895,087
-627,561
-11% -$50.7M 0.05% 393
2016
Q2
$431M Sell
5,522,648
-1,374,444
-20% -$98M 0.06% 351
2016
Q1
$379M Sell
6,897,092
-5,184,188
-43% -$282M 0.05% 375
2015
Q4
$746M Buy
12,081,280
+1,232,461
+11% +$77.7M 0.1% 208
2015
Q3
$684M Buy
10,848,819
+1,582,400
+17% +$113M 0.1% 220
2015
Q2
$677M Buy
9,266,419
+1,567,148
+20% +$113M 0.09% 254
2015
Q1
$504M Buy
7,699,271
+1,830,092
+31% +$122M 0.06% 344
2014
Q4
$382M Buy
5,869,179
+995,111
+20% +$64.1M 0.05% 415
2014
Q3
$293M Sell
4,874,068
-1,848,241
-27% -$121M 0.04% 484
2014
Q2
$466M Sell
6,722,309
-254,932
-4% -$16.5M 0.06% 343
2014
Q1
$456M Sell
6,977,241
-1,305,502
-16% -$85M 0.06% 339
2013
Q4
$513M Buy
8,282,743
+309,023
+4% +$17.9M 0.07% 296
2013
Q3
$428M Sell
7,973,720
-1,940,977
-20% -$100M 0.07% 346
2013
Q2
$452M Buy
+9,914,697
New +$430M 0.07% 309

Other funds holding STJ

Fidelity Investments's STJ Position: Q1 2017 in Review

Fidelity Investments sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 3,478,172 shares — an estimated $279M sold.

Fidelity Investments first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $746M in Q4 2015. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Fidelity Investments reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Fidelity Investments sold 3,478,172 St Jude Medical shares in Q1 2017, an estimated $279M.
  • Fidelity Investments first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Fidelity Investments's St Jude Medical position peaked at $746M in Q4 2015.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Fidelity Investments's 13F filing for Q1 2017, filed 11 May 2017.